InMed Pharmaceuticals Inc. Common Shares
Symbol: INM (NASDAQ)
2.69
▲ (0.19%) 0.005
Company Description:
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
Key Stats
- Today's Open: $2.64
- Today's High: $2.72
- Today's Low: $2.6
- Today's Volume: 40.16K
- Yesterday Close: $2.68
- Yesterday High: $2.75
- Yesterday Low: $2.6323
- Yesterday Volume: 39.87K
- Last Min Volume: 188
- Last Min High: $2.685
- Last Min Low: $2.685
- Last Min VWAP: $2.685
Company Profile
- Name: InMed Pharmaceuticals Inc. Common Shares
- Website: https://www.inmedpharma.com
- Listed Date: 2020-11-10
- Location: VANCOUVER, A1
- Market Status: Active
- CIK Number: 0001728328
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.29M
- Round Lot: 100
- Outstanding Shares: 2.00M
- Asset Type: CS
RECENT FILINGS FOR INM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-09 | S-1 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-24 | 8-K | View |
| 2025-06-13 | 8-K | View |
| 2025-05-29 | DEFA14A | View |
| 2025-05-16 | DEF 14A | View |
| 2025-05-13 | 8-K | View |
| 2025-05-12 | 10-Q | View |
| 2025-04-29 | PRE 14A | View |
| 2025-04-25 | 8-K | View |
| 2025-04-08 | 8-K | View |
| 2025-04-02 | SCHEDULE 13G/A | View |
| 2025-02-14 | 8-K | View |
| 2025-02-13 | 8-K | View |
| 2025-02-12 | 10-Q | View |
| 2025-02-03 | 8-K | View |
| 2025-02-03 | 4 | View |
| 2025-01-22 | 8-K | View |
| 2025-01-21 | 8-K | View |
| 2025-01-03 | SCHEDULE 13G/A | View |
Latest News on INM